June 24, 2024
Medical Probiotics Market

Medical Probiotics Market Propelled by Increasing Adoption of Preventive Healthcare

Medical probiotics are live microorganisms that provide health benefits to users when consumed. These microorganisms help maintain or restore the balance of microorganisms found in the human gut. Medical probiotic products such as dietary supplements and food & beverages play an important role in improving gastrointestinal health, immunity, and overall wellbeing. The Global Medical Probiotics Market Size is estimated to be valued at US$ 4.43 Bn in 2024 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increasing adoption of preventive healthcare among consumers globally has accelerated the demand for medical probiotic products in recent years. Probiotics promote gastrointestinal and immune health and thereby help reduce the risk of various diseases. With growing health consciousness, consumers are increasingly opting for personalized nutrition and prophylactic products like probiotic supplements and foods to improve their overall wellness. Advanced formulations with species-specific strains targeted at specific health conditions are also augmenting the market growth.

SWOT Analysis

Strength: Medical probiotics have various health benefits such as improved digestive health, enhanced immune function, and prevention and treatment of infections. They help maintain a natural balance of microorganisms in the intestinal tract.
Weakness: Limited scientific evidence for some medical claims of probiotics. Stringent regulatory approvals and clinical trials are required to substantiate health claims.
Opportunity: Rising consumer awareness about gut health and digestive issues has boosted the demand for probiotics. Growth of functional food and beverages market also provides opportunities.
Threats: Presence of alternative therapies and lack of standards and guidelines for production and labeling of probiotic products are threats. Stiff competition from domestic and international players is also a challenge.

Key Takeaways

The global medical probiotics market is expected to witness high growth over the forecast period of 2024 to 2030. The market size for 2024 is estimated to be US$ 4.43 Bn with a CAGR of 19%.

Regional analysis: North America currently dominates the market due to increasing digestive issues and growing consumer awareness about gut health. Asia Pacific is expected to grow at the fastest pace owing to rising health consciousness and demand for functional foods in countries like China, India, and Japan.

Key players: Key players operating in the medical probiotics market are Alteryx, Inc., Bentley Systems Incorporated, ESRI, Furgo NV, General Electric, Hexagon AB, Google, Inc., MDA Corporation, Oracle Corporation, SAP SE, Trimble, Inc., and TOMTOM International, Inc. These players are focusing on new product launches, partnerships, and regulatory approvals to strengthen their market presence.

*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it